Neuphoria Therapeutics (NEUP) Operating Income (2023 - 2026)
Neuphoria Therapeutics (NEUP) reported Operating Income of -$1.2 million for Q1 2026, down 110.12% year-over-year from $12.0 million in Q1 2025, and up 70.16% quarter-over-quarter from -$4.1 million in Q4 2025.
Neuphoria Therapeutics (NEUP) Operating Income (2023 - 2026) Analysis & Trends
Neuphoria Therapeutics (NEUP) has 4 years of Operating Income data on file, last reported at -$1.2 million in Q1 2026.
- Operating Income for Q1 2026 came in at -$1.2 million, down 110.12% year-over-year; the trailing twelve-month figure through Mar 2026 was -$16.8 million (down 226.73% YoY), and the FY2025 annual result was -$1.1 million, up 71.01% from the prior year.
- Operating Income improved to -$1.2 million in Q1 2026 per NEUP's latest filing, from -$4.1 million in the prior quarter.
- Over five years, Operating Income peaked at $12.0 million in Q1 2025 and troughed at -$5.8 million in Q2 2025.
- A 4-year average of -$1.4 million and a median of -$3.7 million in 2024 frame the typical range for Operating Income.
- On a YoY basis, Operating Income climbed as much as 600.29% in 2025 and fell as far as 168.49% in 2025.
- A 4-year view of Operating Income shows it stood at -$4.6 million in 2023, then increased by 18.66% to -$3.7 million in 2024, then dropped by 9.65% to -$4.1 million in 2025, then jumped by 70.16% to -$1.2 million in 2026.
- Business Quant data shows NEUP's Operating Income at -$1.2 million in Q1 2026, -$4.1 million in Q4 2025, and -$5.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -15.76 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -65.83 Mn |
| 10 | Neuphoria Therapeutics | 23.86 Mn | 4.46 Mn | - | -1.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.21 Mn |
| Dec 31, 2025 | -4.06 Mn |
| Sep 30, 2025 | -5.65 Mn |
| Jun 30, 2025 | -5.84 Mn |
| Mar 31, 2025 | 11.98 Mn |
| Dec 31, 2024 | -3.70 Mn |
| Sep 30, 2024 | -3.57 Mn |
| Jun 30, 2024 | 8.52 Mn |
| Mar 31, 2024 | -2.39 Mn |
| Dec 31, 2023 | -4.55 Mn |
| Sep 30, 2023 | -5.47 Mn |